Comparing Valtoco vs Xcopri
| Valtoco (diazepam) | Xcopri (cenobamate) |
|
|---|
| Valtoco (diazepam) | Xcopri (cenobamate) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Seizures. Valtoco may also be used for purposes not listed in this medication guide. |
Prescription only
Xcopri is a brand name for cenobamate which may be used to reduce the frequency of partial seizures in adults. In some people, it reduces the frequency to zero. Clumsiness, dizziness, drowsiness... View more |
Related suggestions Seizures
Popular comparisons
|
|||||||
| More about Valtoco (diazepam) | More about Xcopri (cenobamate) | ||||||||
| Ratings & Reviews | |||||||||
|
Be the first to share your experience with this drug. |
Xcopri has an average rating of 8.1 out of 10 from a total of 43 ratings on Drugs.com. 72% of reviewers reported a positive effect, while 5% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Valtoco side effects |
View all Xcopri side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Valtoco prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
|
||||||||
| Brand Names | |||||||||
| Other diazepam brands include: Diastat, Diastat AcuDial, Diastat Pediatric, Diazepam Intensol, Libervant, Valium |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
70 hours |
60 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
Some potential for abuse
Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4. |
||||||||
| Pregnancy Category | |||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 526 drugs are known to interact with Valtoco:
|
A total of 584 drugs are known to interact with Xcopri:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
January 10, 2020 |
November 21, 2019 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.